Pharmaceuticals & Life Sciences - Bubu & Friends

Follow Us:

Pharmaceuticals & Life Sciences

Home Pharmaceuticals & Life Sciences
Use microscope to conduct researches

Pharmaceuticals & Life Sciences Overview

Pharmaceutical industries have been characterized as firms that discover, develop, manufacture, distribute, and market pharmaceutical products. The pharmaceuticals industry consists of drug manufacturers, biotechnology companies and the distribution and wholesale companies that handle the products. The leading companies in this industry are referred to as “Big Pharma” and generate more than fifty percent of the industry’s sales. The majority of these companies are headquartered in the United States, United Kingdom, Switzerland, Germany, and France. Examples are Johnson & Johnson and Abbott Laboratories in the United States; Bayer in Germany; GlaxoSmithKline in the United Kingdom

Our Insights

The industry is known for its competitiveness, large employment, innovation. It is one of the most R&D-intensive industries, which takes up 15%–20% of revenues to R&D activities in the United States, and a fast-growing segment of biologics and generics. The competition is increasingly challenging, being driven by a more and more demanding healthcare agenda. The global need for innovative, cost-effective medicines continues to rise since consumers are demanding greater value for money, proven effectiveness of products, more transparency and access to information. Companies are seeking ways to improve R&D productivity, spending on sales and marketing and enhance financial performance to meet the shifting global demand. Over-regulation has always been one of the major perceived threats by the industry. Also, digitalisation impacts on the industry greatly, as the digital age requires more transparency and disclosure and a need for real relationship-driven partnerships will extend to all stakeholders. While digitisation continues to shape the industry, a new generation of startups and tech giants have emerged which disrupts the status quo and threatens current pharma’s legacy culture. Speed of technological change is one of the concerns, while cyber threat is also gaining more focus. With the COVID-19 epidemic, society and governments have paid more attention to the healthcare and pharmaceutical industries, which will impose both positive and negative consequences.

News and Insights

Looking For Overseas Opportunities?
As your global business experts, we deliver a more efficient, cost-effective, and focused approach to your business. We are ready to take your business to international levels, no matter where you want to go.